John W Ostrominski
Overview
Explore the profile of John W Ostrominski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ostrominski J, Claggett B, Jerosch-Herold M, Raja A, Day S, Russell M, et al.
JAMA Cardiol
. 2025 Mar;
PMID: 40042824
Importance: Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Myocardial tissue characterization by cardiac magnetic resonance (CMR) imaging may enhance mechanistic insights,...
2.
Ostrominski J, Claggett B, Miao Z, Filippatos G, Desai A, Jhund P, et al.
Diabetes Care
. 2025 Feb;
PMID: 40019856
Objective: To evaluate the efficacy and safety of finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in individuals with type 2 diabetes (T2D) and either chronic kidney disease (CKD) or heart failure...
3.
Ostrominski J, Plutzky J, Sattar N, Vaduganathan M, Aroda V
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39911097
No abstract available.
4.
Ostrominski J, Aroda V
Lancet Diabetes Endocrinol
. 2025 Jan;
13(3):169-170.
PMID: 39848269
No abstract available.
5.
Ostrominski J, Wagholikar K, Olsson K, Unlu O, Zelle D, Kumar S, et al.
Obesity (Silver Spring)
. 2024 Dec;
33(2):365-384.
PMID: 39696750
Objective: The objective of this study was to describe the prevalence of obesity, obesity-related conditions (ORCs), and antiobesity medication (AOM) eligibility and prescribing practice among eligible patients in a large...
6.
Subramaniam S, Hassan S, Unlu O, Kumar S, Zelle D, Ostrominski J, et al.
Popul Health Manag
. 2024 Dec;
27(6):374-381.
PMID: 39630562
A majority of patients with heart failure (HF) do not receive adequate medical therapy as recommended by clinical guidelines. One major obstacle encountered by population health management (PHM) programs to...
7.
Saeed Z, Ostrominski J, Aroda V
Diabetes Care
. 2024 Nov;
47(12):2104-2106.
PMID: 39602592
No abstract available.
8.
Ostrominski J, Hojbjerg Lassen M, Claggett B, Miao Z, Inzucchi S, Docherty K, et al.
Eur Heart J
. 2024 Nov;
PMID: 39568016
Background And Aims: Individuals with heart failure (HF), other forms of cardiovascular disease, or kidney disease are at increased risk for the development and adverse health effects of diabetes. As...
9.
Ostrominski J, Seferovic P, Selvaraj S
Eur J Heart Fail
. 2024 Nov;
PMID: 39513355
No abstract available.
10.
Ostrominski J, Cho S, Vaduganathan M, Honigberg M
Diabetes Obes Metab
. 2024 Oct;
27(1):422-427.
PMID: 39402726
No abstract available.